Wellington Management Group’s Praxis Precision Medicines PRAX Stock Holding History

Wellington Management Group’s Portfolio PRAX Stock Details PRAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$42.1M	Sell	125,867 -48,483	-28%	-$15.3M	0.01%	800
2026 Q1	$56.2M	Sell	174,350 -2,212	-1%	-$684K	0.01%	703
2025 Q4	$52M	Buy	176,562 +115,321	+188%	+$21.5M	0.01%	728
2025 Q3	$3.25M	Buy	61,241 +5,360	+10%	+$260K	﹤0.01%	1526
2025 Q2	$2.35M	Buy	55,881 +5,105	+10%	+$194K	﹤0.01%	1537
2025 Q1	$1.92M	Sell	50,776 -13,158	-21%	-$822K	﹤0.01%	1569
2024 Q4	$4.92M	Sell	63,934 -155,973	-71%	-$11.3M	﹤0.01%	1353
2024 Q3	$12.7M	Buy	219,907 +168,394	+327%	+$9.1M	﹤0.01%	1101
2024 Q2	$2.13M	Buy	51,513 +11,948	+30%	+$565K	﹤0.01%	1501
2024 Q1	$2.41M	Buy	+39,565	New	+$1.77M	﹤0.01%	1481

Other funds holding PRAX

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Wellington Management Group's PRAX Position: Q2 2026 in Review

Wellington Management Group reduced its Praxis Precision Medicines (PRAX) stake by 28% in Q2 2026, selling an estimated $15.3M and leaving 125,867 shares worth $42.1M. The position accounts for 0.01% of the portfolio, ranked #800.

Wellington Management Group first reported a position in PRAX in Q1 2024 and has held it in 10 quarters since. The position peaked at $56.2M in Q1 2026. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

Wellington Management Group held 125,867 shares of Praxis Precision Medicines worth $42.1M as of Q2 2026.
Wellington Management Group sold 48,483 Praxis Precision Medicines shares in Q2 2026, an estimated $15.3M.
Praxis Precision Medicines made up 0.01% of Wellington Management Group's portfolio in Q2 2026, its #800 holding.
Wellington Management Group first reported a position in Praxis Precision Medicines in Q1 2024 and has held it in 10 quarters since.
Wellington Management Group's Praxis Precision Medicines position peaked at $56.2M in Q1 2026.
309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.